首页 | 本学科首页   官方微博 | 高级检索  
检索        

肾缺血再灌注损伤中蛋白激酶C对巨噬细胞的影响
引用本文:肖婷.肾缺血再灌注损伤中蛋白激酶C对巨噬细胞的影响[J].海南医学,2017,27(8).
作者姓名:肖婷
作者单位:遵义医学院附属医院肾内科,贵州 遵义,563003
摘    要:缺血再灌注损伤是器官移植不可避免的反应过程,其病理生理机制包括细胞凋亡、氧自由基生成、免疫系统活化、微血管功能障碍等.其中先天免疫是机体防御的第一道防线,也是关键环节,而巨噬细胞是肾脏缺血性先天免疫早期重要的起动子,在缺血再灌注损伤中发挥双剑作用.因此,在早期减轻巨噬细胞的浸润是目前的研究热点.而蛋白激酶C抑制剂能通过多途径作用减少移植肾内的巨噬细胞浸润,但目前具体机制尚不完全清楚.

关 键 词:肾缺血再灌注损伤  先天免疫  巨噬细胞  蛋白激酶C

Influence of protein kinase C on macrophages in renal ischemia-reperfusion injury
XIAO Ting.Influence of protein kinase C on macrophages in renal ischemia-reperfusion injury[J].Hainan Medical Journal,2017,27(8).
Authors:XIAO Ting
Abstract:Ischemia-reperfusion injury (IRI) is inevitable for organ transplantation, and its pathophysiological mechanisms include apoptosis, generation of reactive oxygen species (ROS), innate immune system activation, microvas-cular dysfunction. The innate immune system is the first line of defense, also a critical component of organ transplanta-tion. Macrophages are the critical early initiator of innate immunity in the kidney, which play a dual role in renal isch-emia-reperfusion injury. Therefore, how to reduce macrophage infiltration is a hotspot of ischemia-reperfusion injury. Protein kinase C inhibitors can reduce macrophage infiltrate in the renal allografts through multiple pathways, but how it works is still unclear.
Keywords:Renal ischemia-reperfusion injury (IRI)  Innate immune system  Macrophage  Protein kinase C (PKC)
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号